Brief: Diaxonhit FY Operating Loss Narrows To 3.7 Million Euros

Eurobio Scientific SA

23/04/2018 16:52

April 23 (Reuters) - DIAXONHIT SA  ALEHT.PA :
    * FY NET LOSS EUR 10.0 MILLION VERSUS LOSS OF EUR 7.7
MILLION YEAR
AGO
    * FY OPERATING REVENUE EUR 43.1 MILLION VERSUS EUR 28.4
MILLION
YEAR AGO
    * FY OPERATING LOSS EUR 3.7 MILLION VERSUS LOSS OF EUR 7.1
MILLION
YEAR AGO
    * IN 2018 WANTS TO SIGNIFICANTLY BOOST REVENUE AND EBITDA
    * AIMS TO INCREASE REVENUE BY 25 PERCENT OVER NEXT 3 YRS
    * IN 2018, TO DEVELOP DIAGNOSTIC RANGE EBX
    * IN 2018, TO PURSUE ITS EXTERNAL GROWTH
    * IN 2018, TO SIGN NEW DISTRIBUTION AGREEMENTS TO OFFER
PRODUCTS
SUCH AS NGS

Source text for Eikon:  ID:nGNE7HyVYb 
Further company coverage:  ALEHT.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))